BackApexigen- Warrants (29/07/2027) Overview

Apexigen- Warrants (29/07/2027) Other Current Liabilities

Apexigen- Warrants (29/07/2027)'s other current liabilities is $5.4M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$5.36M
99.86% YoYΔ $-3.81B vs prior year quarter

Peer trimmed avg / median

Loading

Apexigen- Warrants (29/07/2027) Other Current Liabilities History

Loading

Apexigen- Warrants (29/07/2027) vs. peers: Other Current Liabilities Comparison

Loading

Apexigen- Warrants (29/07/2027) Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Apexigen- Warrants (29/07/2027) (APGNW) FAQ

The latest other current liabilities for APGNW is $5.4M as of June 2023. That compares with $3.8B in the prior-year period — down 99.9% year over year. Investors often review this figure alongside Apexigen- Warrants (29/07/2027)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, APGNW's other current liabilities moved from $3.8B to $5.4M — a 99.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Apexigen- Warrants (29/07/2027)'s operating scale or balance-sheet position.

A other current liabilities figure of $5.4M for APGNW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting APGNW's other current liabilities ($5.4M), review year-over-year change from $3.8B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.